[COLPOSCOPIC, CYTOLOGIC AND HISTOLOGIC FINDINGS IN THE PORTIO UTERI DURING OVULATION INHIBITING MEDICATION].
D002584:Cervix Uteri; D003127:Colposcopy; D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D005260:Female; D006801:Humans; D008656:Mestranol; D009369:Neoplasms / Q000175:diagnosis* / Q000209:etiology*; D009640:Norethindrone; D009641:Norethynodrel; D010060:Ovulation; D011247:Pregnancy; D014116:Toxicology; D002583:Uterine Cervical Neoplasms; D014626:Vaginal Smears
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D008656:Mestranol; D009640:Norethindrone
CERVIX NEOPLASMS; CERVIX UTERI; COLPOSCOPY; CONTRACEPTIVES, ORAL; ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE; MESTRANOL; NEOPLASM DIAGNOSIS; NEOPLASM ETIOLOGY; NORETHINDRONE; NORETHYNODREL; TOXICOLOGIC REPORT; VAGINAL SMEARS
KOLPOSKOPISCHE, ZYTOLOGISCHE UND HISTOLOGISCHE PORTIOBEFUNDE UNTER OVULATIONSHEMMENDER MEDIKATION.